REFERENCES
- Berger , R. L. , Hsu , J. C. ( 1996 ). Bioequivalence trials, intersection–union tests and equivalence confidence interval sets . Stat. Sci. 11 : 283 – 302 .
- Boos , D. , Hoffman , D. , Kringle , R. , Zhang , J. ( 2007 ). New confidence bounds for QT studies . Stat. Med. 26 : 3801 – 3817 .
- Eaton , M. L. , Muirhead , R. J. , Mancuso , J. Y. , Lolluri , S. ( 2006 ). A confidence interval for the maximal mean QT interval change due drug effect . Drug Information J. 40 : 267 – 271 .
- Garnett , C. E. , Beasley , N. , Bhattaran , V. A. , Jadhav , P. R. , Madabushi , R. , Stockbridge , N. , Tornee , C. W. , Wang , Y. , Gobburu , J. V. ( 2008 ). Concentration–QT relationships play a key role in the evaluation of proarrhythmic risk during regulatory review . J. Clin. Pharmacol. 48 : 13 – 18 .
- Holford , N. H. , Coates , P. E. , Guentert , T. W. , Riegelman , S. , Sheiner , L. B. ( 1981 ). The effect of quinidine and its metabolites on the electrocardiogram and systolic time intervals: Concentration–effect relationships . Br. J. Clin. Pharmacol. 11 : 187 – 195 .
- International Conference on Harmonization. ( 2005 ). ICH (E14) Guidance. The Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs . International Conference on Harmonization, May, Geneva, Switzerland .
- Patterson , S. , Jones , B. ( 2005 ). Bioequivalence and Statistics in Clinical Pharmacology . London : Chapman and Hall, CRC Press .
- Ring , A. , Glomb , P. ( 2008 ). Impact of Delayed Effects in the Exposure-Response Analysis of Clinical QT Trials . 2008 FDA/Industry Statistics Workshop, September, Washington, DC .
- Tsong , Y. , Shen , M. , Zhong , J. , Zhang , J. (2008). Statistical issues of QT prolongation assessment based on linear concentration modeling. J. Biopharm. Stat. 18(3):564–584.
- Wang , Y. ( 2008 ). Simulation Based Evaluation of Concentration–QTc (CQTc) Analysis . 2008 FDA/Industry Statistics Workshop, September, Washington, DC .